Roche accuses competitor of infringing diabetes patent
22-06-2020
Fed Circuit restores two Illumina DNA patents in blow to Roche
19-03-2020
Genentech in $1.7bn immuno-oncology deal
27-02-2020
Testing / Shutterstock.com
Swiss healthcare company Roche has partnered with Chinese biotech Innovent Biologics to develop cell therapies and bispecific antibodies.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Roche, Innovent Biologics, collaboration, research and development, cancer, Michael Yu, CAR-T, biotech
